Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Nathan

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Psychological Medicine|June 19, 2012
Speed of facial affect intensity recognition as an endophenotype of first-episode psychosis and associated limbic-cortical grey matter systemsA M Dean, E Goodby, C Ooi, et al.
Psychopharmacology|October 25, 2008
Galantamine-induced improvements in cognitive function are not related to alterations in alpha(4)beta (2) nicotinic receptors in early Alzheimer's disease as measured in vivo by 2-[18F]fluoro-A-85380 PETJ R Ellis, P J Nathan, V L Villemagne, et al.
Human Psychopharmacology|September 21, 2004
Evidence for synergistic modulation of early information processing by nicotinic and muscarinic receptors in humansF F Erskine, J R Ellis, K A Ellis, et al.
Synapse (New York, N.Y.)|June 2, 2009
The relationship between nicotinic receptors and cognitive functioning in healthy aging: An in vivo positron emission tomography (PET) study with 2-[(18)F]fluoro-A-85380J R Ellis, P J Nathan, V L Villemagne, et al.
Neurobiology of Learning and Memory|July 16, 2008
Relationship between nicotinic receptors and cognitive function in early Alzheimer's disease: a 2-[18F]fluoro-A-85380 PET studyJ R Ellis, V L Villemagne, P J Nathan, et al.
Translational Psychiatry|April 1, 2015
Behavioural and molecular endophenotypes in psychotic disorders reveal heritable abnormalities in glutamatergic neurotransmissionL Scoriels, R M Salek, E Goodby, et al.
Molecular Psychiatry|April 20, 2011
Pharmacological differentiation of opioid receptor antagonists by molecular and functional imaging of target occupancy and food reward-related brain activation in humansE A Rabiner, J Beaver, A Makwana, et al.
Molecular Psychiatry|November 14, 2012
Effects of the mu-opioid receptor antagonist GSK1521498 on hedonic and consummatory eating behaviour: a proof of mechanism study in binge-eating obese subjectsH Ziauddeen, S R Chamberlain, P J Nathan, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Psychological Medicine|June 19, 2012
Speed of facial affect intensity recognition as an endophenotype of first-episode psychosis and associated limbic-cortical grey matter systemsA M Dean, E Goodby, C Ooi, et al.
Psychopharmacology|October 25, 2008
Galantamine-induced improvements in cognitive function are not related to alterations in alpha(4)beta (2) nicotinic receptors in early Alzheimer's disease as measured in vivo by 2-[18F]fluoro-A-85380 PETJ R Ellis, P J Nathan, V L Villemagne, et al.
Human Psychopharmacology|September 21, 2004
Evidence for synergistic modulation of early information processing by nicotinic and muscarinic receptors in humansF F Erskine, J R Ellis, K A Ellis, et al.
Synapse (New York, N.Y.)|June 2, 2009
The relationship between nicotinic receptors and cognitive functioning in healthy aging: An in vivo positron emission tomography (PET) study with 2-[(18)F]fluoro-A-85380J R Ellis, P J Nathan, V L Villemagne, et al.
Neurobiology of Learning and Memory|July 16, 2008
Relationship between nicotinic receptors and cognitive function in early Alzheimer's disease: a 2-[18F]fluoro-A-85380 PET studyJ R Ellis, V L Villemagne, P J Nathan, et al.
Translational Psychiatry|April 1, 2015
Behavioural and molecular endophenotypes in psychotic disorders reveal heritable abnormalities in glutamatergic neurotransmissionL Scoriels, R M Salek, E Goodby, et al.
Molecular Psychiatry|April 20, 2011
Pharmacological differentiation of opioid receptor antagonists by molecular and functional imaging of target occupancy and food reward-related brain activation in humansE A Rabiner, J Beaver, A Makwana, et al.
Molecular Psychiatry|November 14, 2012
Effects of the mu-opioid receptor antagonist GSK1521498 on hedonic and consummatory eating behaviour: a proof of mechanism study in binge-eating obese subjectsH Ziauddeen, S R Chamberlain, P J Nathan, et al.
Pageof 4